U.S. Vaccine Program Now Flush With Cash, but Short on Key Details - Distinguished

U.S. Vaccine Program Now Flush With Cash, but Short on Key Details

Start
A $5 billion federal program aims to make better Covid vaccines. But vaccine makers are confused by murky regulatory guidance.
Previous Story

Officials question whether truce will hold in Kremlin, Wagner standoff

Next Story

In Pitch to Evangelicals, Trump Casts Himself as Christian Crusader Who Helped End Roe v. Wade